Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT05537038
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 120
Large-scale testing (Phase 3)Study completedNCT00996606
What this trial is testing

Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 58
Testing effectiveness (Phase 2)Study completedNCT00595413
What this trial is testing

Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

Who this might be right for
Rheumatoid Arthritis
EMD Serono 311
Large-scale testing (Phase 3)Study completedNCT02720523
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 197
Large-scale testing (Phase 3)Ended earlyNCT00476996
What this trial is testing

Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 836
Early research (Phase 1)Study completedNCT00002403
What this trial is testing

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

Who this might be right for
HIV Infections
Aronex Pharmaceuticals 12
Post-approval studies (Phase 4)Study completedNCT01399697
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 261
Testing effectiveness (Phase 2)Study completedNCT00810836
What this trial is testing

Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 153
Testing effectiveness (Phase 2)Study completedNCT01242488
What this trial is testing

Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 221
Not applicableLooking for participantsNCT03875703
What this trial is testing

Post-Vaccination Biological Collection

Who this might be right for
VaccinationImmune Response
Assistance Publique - Hôpitaux de Paris 1,200
Testing effectiveness (Phase 2)Study completedNCT01373151
What this trial is testing

Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
CSL Behring 418
Post-approval studies (Phase 4)Study completedNCT02655874
What this trial is testing

Tropical Influenza Control Strategies for the Elderly

Who this might be right for
Influenza, Human
Tan Tock Seng Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT00458861
What this trial is testing

BG9924 in Combination With Methotrexate for Participants With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 115
Large-scale testing (Phase 3)Active Not RecruitingNCT02629159
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
AbbVie 1,629
Large-scale testing (Phase 3)Study completedNCT01835470
What this trial is testing

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan

Who this might be right for
Juvenile Idiopathic Arthritis
Bristol-Myers Squibb 23
Not applicableStudy completedNCT00157066
What this trial is testing

Effects of Vitamin D Supplementation on Antimycobacterial Immunity

Who this might be right for
Tuberculosis
Barts & The London NHS Trust 230
Not applicableStudy completedNCT01613027
What this trial is testing

An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 135
Testing effectiveness (Phase 2)Study completedNCT02202395
What this trial is testing

Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Shanghai Pharmaceuticals Holding Co., Ltd 120
Not applicableLooking for participantsNCT07680556
What this trial is testing

Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Oncology
Radboud University Medical Center 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation